We are a research-based specialty
biopharma company determined
to give people all over the world a
longer and better life

We are developing the first vaccine
in the world for protection against
diarrhoea caused by ETEC in both
travellers and endemic populations

We distribute a wide range of
specialty biopharma products with
focus on vaccines and immunoglobulins

Scandinavian Biopharma

Welcome to Scandinavian Biopharma,

We are an entrepreneurial company specialised in global vaccine development, manufacturing, registration and commercialization of biopharmaceutical products. Our team has previously successfully developed, manufactured, registered and globally l[...]
Read more


Scandinavian Biopharma

Scandinavian Biopharma enters into a commercial collaboration with Novavax in Sweden

Scandinavian Biopharma and Novavax have signed a commercial collaboration agreement for the Covid vaccine Nuvaxovid. Nuvaxovid is an adjuvanted protein-based vaccine that protects against SARS Covid-19. Scandinavian Biopharma has extensive ex[...]
Read more


Scandinavian Biopharma

Scandinavian Biopharma has successfully completed the enrolment of their large Phase IIb trial in The Gambia

We are proud to announce that all participants have received the third and final vaccination dose in our large randomized, placebo-controlled, and double-blind phase IIb study in The Gambia. The study started in 2021 and is part of the late p[...]
Read more